Monthly Weekly Daily List
September 2019
October 2019
No event found!
Type of events :
  • Financial results and general meetings
  • Analyst conferences
  • Investor conferences
  • Scientific congresses
  • Other events

Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.

Contact Us

9 + 13 =

© 2019 Advicenne